Global Central Nervous System (CNS) Drug Market Research Report 2022

Global Central Nervous System (CNS) Drug Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 MS Therapeutics
1.3.3 Antipsychotic Drugs
1.3.4 Depression Drugs
1.3.5 Epilepsy Drugs
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Drug Market Perspective (2017-2028)
2.2 Central Nervous System (CNS) Drug Growth Trends by Region
2.2.1 Central Nervous System (CNS) Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Central Nervous System (CNS) Drug Historic Market Size by Region (2017-2022)
2.2.3 Central Nervous System (CNS) Drug Forecasted Market Size by Region (2023-2028)
2.3 Central Nervous System (CNS) Drug Market Dynamics
2.3.1 Central Nervous System (CNS) Drug Industry Trends
2.3.2 Central Nervous System (CNS) Drug Market Drivers
2.3.3 Central Nervous System (CNS) Drug Market Challenges
2.3.4 Central Nervous System (CNS) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Drug Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Drug Players by Revenue (2017-2022)
3.1.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2017-2022)
3.2 Global Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Central Nervous System (CNS) Drug Revenue
3.4 Global Central Nervous System (CNS) Drug Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Drug Revenue in 2021
3.5 Central Nervous System (CNS) Drug Key Players Head office and Area Served
3.6 Key Players Central Nervous System (CNS) Drug Product Solution and Service
3.7 Date of Enter into Central Nervous System (CNS) Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Drug Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Drug Historic Market Size by Type (2017-2022)
4.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2023-2028)
5 Central Nervous System (CNS) Drug Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Drug Historic Market Size by Application (2017-2022)
5.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Central Nervous System (CNS) Drug Market Size (2017-2028)
6.2 North America Central Nervous System (CNS) Drug Market Size by Country (2017-2022)
6.3 North America Central Nervous System (CNS) Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Drug Market Size (2017-2028)
7.2 Europe Central Nervous System (CNS) Drug Market Size by Country (2017-2022)
7.3 Europe Central Nervous System (CNS) Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size (2017-2028)
8.2 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Drug Market Size (2017-2028)
9.2 Latin America Central Nervous System (CNS) Drug Market Size by Country (2017-2022)
9.3 Latin America Central Nervous System (CNS) Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size (2017-2028)
10.2 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Introduction
11.1.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Detail
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Central Nervous System (CNS) Drug Introduction
11.2.4 Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.2.5 Pfizer Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Central Nervous System (CNS) Drug Introduction
11.3.4 Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.3.5 Novartis AG Recent Development
11.4 GSK
11.4.1 GSK Company Detail
11.4.2 GSK Business Overview
11.4.3 GSK Central Nervous System (CNS) Drug Introduction
11.4.4 GSK Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.4.5 GSK Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Central Nervous System (CNS) Drug Introduction
11.5.4 Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.5.5 Eli Lilly Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Central Nervous System (CNS) Drug Introduction
11.6.4 Teva Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.6.5 Teva Recent Development
11.7 Otsuka Pharmaceutical Co., Ltd
11.7.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.7.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Introduction
11.7.4 Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.7.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.8 Biogen Inc
11.8.1 Biogen Inc Company Detail
11.8.2 Biogen Inc Business Overview
11.8.3 Biogen Inc Central Nervous System (CNS) Drug Introduction
11.8.4 Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.8.5 Biogen Inc Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Introduction
11.9.4 Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Central Nervous System (CNS) Drug Introduction
11.10.4 Roche Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.10.5 Roche Recent Development
11.11 UCB
11.11.1 UCB Company Detail
11.11.2 UCB Business Overview
11.11.3 UCB Central Nervous System (CNS) Drug Introduction
11.11.4 UCB Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.11.5 UCB Recent Development
11.12 Tekeda
11.12.1 Tekeda Company Detail
11.12.2 Tekeda Business Overview
11.12.3 Tekeda Central Nervous System (CNS) Drug Introduction
11.12.4 Tekeda Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.12.5 Tekeda Recent Development
11.13 Shanghai Fosun
11.13.1 Shanghai Fosun Company Detail
11.13.2 Shanghai Fosun Business Overview
11.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Introduction
11.13.4 Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.13.5 Shanghai Fosun Recent Development
11.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Detail
11.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Introduction
11.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2017-2022)
11.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC
Table 4. Global Central Nervous System (CNS) Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Central Nervous System (CNS) Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Central Nervous System (CNS) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Central Nervous System (CNS) Drug Market Share by Region (2017-2022)
Table 8. Global Central Nervous System (CNS) Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Central Nervous System (CNS) Drug Market Share by Region (2023-2028)
Table 10. Central Nervous System (CNS) Drug Market Trends
Table 11. Central Nervous System (CNS) Drug Market Drivers
Table 12. Central Nervous System (CNS) Drug Market Challenges
Table 13. Central Nervous System (CNS) Drug Market Restraints
Table 14. Global Central Nervous System (CNS) Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Central Nervous System (CNS) Drug Market Share by Players (2017-2022)
Table 16. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2021)
Table 17. Ranking of Global Top Central Nervous System (CNS) Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Central Nervous System (CNS) Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Central Nervous System (CNS) Drug Product Solution and Service
Table 21. Date of Enter into Central Nervous System (CNS) Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Central Nervous System (CNS) Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Central Nervous System (CNS) Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2017-2022)
Table 29. Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2023-2028)
Table 31. North America Central Nervous System (CNS) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Central Nervous System (CNS) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Central Nervous System (CNS) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Central Nervous System (CNS) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Central Nervous System (CNS) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Central Nervous System (CNS) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Johnson & Johnson Company Detail
Table 42. Johnson & Johnson Business Overview
Table 43. Johnson & Johnson Central Nervous System (CNS) Drug Product
Table 44. Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 45. Johnson & Johnson Recent Development
Table 46. Pfizer Inc Company Detail
Table 47. Pfizer Inc Business Overview
Table 48. Pfizer Inc Central Nervous System (CNS) Drug Product
Table 49. Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 50. Pfizer Inc Recent Development
Table 51. Novartis AG Company Detail
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Central Nervous System (CNS) Drug Product
Table 54. Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. GSK Company Detail
Table 57. GSK Business Overview
Table 58. GSK Central Nervous System (CNS) Drug Product
Table 59. GSK Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 60. GSK Recent Development
Table 61. Eli Lilly Company Detail
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Central Nervous System (CNS) Drug Product
Table 64. Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Teva Company Detail
Table 67. Teva Business Overview
Table 68. Teva Central Nervous System (CNS) Drug Product
Table 69. Teva Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 70. Teva Recent Development
Table 71. Otsuka Pharmaceutical Co., Ltd Company Detail
Table 72. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 73. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product
Table 74. Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 75. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 76. Biogen Inc Company Detail
Table 77. Biogen Inc Business Overview
Table 78. Biogen Inc Central Nervous System (CNS) Drug Product
Table 79. Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 80. Biogen Inc Recent Development
Table 81. Boehringer Ingelheim Company Detail
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Central Nervous System (CNS) Drug Product
Table 84. Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 85. Boehringer Ingelheim Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche Central Nervous System (CNS) Drug Product
Table 89. Roche Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 90. Roche Recent Development
Table 91. UCB Company Detail
Table 92. UCB Business Overview
Table 93. UCB Central Nervous System (CNS) DrugProduct
Table 94. UCB Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 95. UCB Recent Development
Table 96. Tekeda Company Detail
Table 97. Tekeda Business Overview
Table 98. Tekeda Central Nervous System (CNS) DrugProduct
Table 99. Tekeda Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 100. Tekeda Recent Development
Table 101. Shanghai Fosun Company Detail
Table 102. Shanghai Fosun Business Overview
Table 103. Shanghai Fosun Central Nervous System (CNS) DrugProduct
Table 104. Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 105. Shanghai Fosun Recent Development
Table 106. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Detail
Table 107. Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
Table 108. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) DrugProduct
Table 109. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2017-2022) & (US$ Million)
Table 110. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Drug Market Share by Type: 2021 VS 2028
Figure 2. Prescription Drugs Features
Figure 3. OTC Features
Figure 4. Global Central Nervous System (CNS) Drug Market Share by Application in 2021 & 2028
Figure 5. MS Therapeutics Case Studies
Figure 6. Antipsychotic Drugs Case Studies
Figure 7. Depression Drugs Case Studies
Figure 8. Epilepsy Drugs Case Studies
Figure 9. Others Case Studies
Figure 10. Central Nervous System (CNS) Drug Report Years Considered
Figure 11. Global Central Nervous System (CNS) Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Central Nervous System (CNS) Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Central Nervous System (CNS) Drug Market Share by Region: 2021 VS 2028
Figure 14. Global Central Nervous System (CNS) Drug Market Share by Players in 2021
Figure 15. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Drug Revenue in 2021
Figure 17. North America Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Central Nervous System (CNS) Drug Market Share by Country (2017-2028)
Figure 19. United States Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Central Nervous System (CNS) Drug Market Share by Country (2017-2028)
Figure 23. Germany Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2017-2028)
Figure 31. China Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Central Nervous System (CNS) Drug Market Share by Country (2017-2028)
Figure 39. Mexico Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2017-2028)
Figure 43. Turkey Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Central Nervous System (CNS) Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 46. Pfizer Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 47. Novartis AG Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 48. GSK Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 49. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 50. Teva Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 51. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 52. Biogen Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 54. Roche Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 55. UCB Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 56. Tekeda Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 57. Shanghai Fosun Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 58. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs